Top searches

PL

Resources

B2RLaw advises biotech company Ambulero on fundraising

27/01/2021

B2RLaw has advised Ambulero, Inc., a biotechnology company developing cell and gene therapy treatments for patients suffering from vascular disease on funding of up to USD 5.5 million received from from Orphinic Scientific.

As part of the investment, and with the help of B2RLaw, Ambulero and Orphinic formed a Polish subsidiary (Ambulero Sp. z o.o.) that will lead clinical testing of a novel gene therapy for a serious vascular disease in Europe. The disease is rare in the US but more common in certain parts of Central and Eastern Europe.

Ambulero is a biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases. The company is a 2019 spin-out of the University of Miami co-founded by Robert L. Buchanan, Randy Berholtz, Omaida C. Velazquez and Jun Zhao-Liu. It holds an exclusive license from the University of Miami to develop and commercialize research from the laboratories of Drs. Omaida C. Velazquez and Jun Zhao-Liu.

With offices in Palo Alto, California and Warsaw, Poland, Orphinic Scientific is an innovative drug development and investment company focused on mid-market opportunities and orphan drugs in late preclinical research and Phase 1 or 2.

B2RLaw’s team was led by Partner Szymon Syp and included Senior Associate Iga Wojtczak – Opala and Junior Associate Jakub Niemiec.

Szymon Syp advises, “We congratulate Ambulero and Orphinic Scientific on this transaction. Ambulero’s important work means that people that suffer from serious vascular disease (which at best, causes severe discomfort and at worst, can result in death) can live in comfort with the knowledge that innovative treatment is on the horizon. We wish Ambulero the best of luck on its future clinical testing”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

14/01/2022

B2RLaw advises Focus Estate Fund on the acquisition of Turawa Park shopping center

B2RLaw has advised real estate investment fund Focus Estate Fund on the acquisition of Turawa Park shopping center in Opole, […]

MORE
13/01/2022

B2RLaw advises on PLN 2 million investment into fintech company, Digital Gateways

B2RLaw has advised private investors on their PLN 2 million investment into fintech company Digital Gateways. Digital Gateways is a […]

MORE
30/12/2021

B2RLaw advises VC fund Meta Ventures on investment received by portfolio company Car Scanner

B2RLaw has advised Meta Ventures on portfolio company Car Scanner’s USD 2 million investment round. Meta Ventures, an early-stage venture […]

MORE
20/12/2021

B2RLaw advises Keyloop on its office lease to enter the Polish market

B2RLaw has advised Keyloop on its entry to the Polish market through the opening of its first office in Warsaw. […]

MORE
13/12/2021

B2RLaw advises InsurTech Gabi on Polish law aspects of its acquisition by Experian for USD 320 million

B2RLaw has advised InsurTech company Gabi on Polish law aspects of its acquisition by global information services company Experian for […]

MORE
17/11/2021

A Discussion on Venture Debt

For emerging companies, gaining access to financial resources can be a challenge. Traditional bank loans are often unavailable, and the […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close